http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013190245-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9bf2cf398ea8278879869cc4b2a5665c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b7035ddeafd4070f46389322bb042e72
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-102
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-001
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-00
filingDate 2010-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37c6cc4d5ea3ee8d92f71168bf6466c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5cfd053fc3d00941d5b12951644eb74a
publicationDate 2013-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2013190245-A1
titleOfInvention Light Activated Composite Tissue Adhesives
abstract A light activated collagen-flavin composite layer incorporating riboflavin is applied as treatment for infected lesions caused by bacteria and as the consequence of surgical procedures. These composites have also been found to be strong tissue adhesives that are effective in closing and sealing wounds, fixation of grafts/ implants and anastomoses. Advantages include speed of closure, reduced infection due to the elimination of foreign matter, evidence of accelerated wound healing and the ease of use in complex surgery, especially when watertight seals, limited access or small repair size are important factors. The riboflavin in the collagen layer is exposed to light (e.g., light having a wavelength between 360-375 nm or 440-480 nm), decomposing the riboflavin to form reactive oxygen species (ROS). Strong crosslinks between the collagen composite and tissue results. In addition, similar exposures eradicate pathogens in the wound is eradicated resulting in a sterile wound. In other examples, the composite film may instead contain lumichrome or lumiflavin.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011125187-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015089020-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9655707-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11324823-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015157439-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9888991-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016148958-A1
priorityDate 2010-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6875427-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127461181
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226552723
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399047
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282412
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409544
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66184
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5326566
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25473
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405859
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413167
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129447284
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID493570
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4737
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10800
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14476402
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5707
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226553627
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6759
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412265
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7940
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410155

Total number of triples: 46.